China is now a well-established and critical life science growth market, but its legal and regulatory landscape continues to evolve at pace. This cross-practice roundtable will examine China’s IP enforcement trends, regulatory reform, competition scrutiny and deal landscape, discussing the core risks and opportunities for companies expanding into and currently operating in this crucial jurisdiction.
Agenda Track No.:
Track 3
Session Type:
General Session (Presentation)
Force Inline Description:
0